PL361139A1 - Assay for soluble fibrin - Google Patents
Assay for soluble fibrinInfo
- Publication number
- PL361139A1 PL361139A1 PL36113901A PL36113901A PL361139A1 PL 361139 A1 PL361139 A1 PL 361139A1 PL 36113901 A PL36113901 A PL 36113901A PL 36113901 A PL36113901 A PL 36113901A PL 361139 A1 PL361139 A1 PL 361139A1
- Authority
- PL
- Poland
- Prior art keywords
- assay
- soluble fibrin
- fibrin
- soluble
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0010999A FR2813395B1 (en) | 2000-08-28 | 2000-08-28 | METHOD OF IN VITRO DETERMINATION OF SOLUBLE FIBRIN BY GENERATION OF SPECIFIC DEGRADATION PRODUCTS |
PCT/FR2001/002628 WO2002018628A1 (en) | 2000-08-28 | 2001-08-17 | Assay for soluble fibrin |
Publications (1)
Publication Number | Publication Date |
---|---|
PL361139A1 true PL361139A1 (en) | 2004-09-20 |
Family
ID=8853768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL36113901A PL361139A1 (en) | 2000-08-28 | 2001-08-17 | Assay for soluble fibrin |
Country Status (19)
Country | Link |
---|---|
US (2) | US8883433B2 (en) |
EP (1) | EP1313877B1 (en) |
JP (1) | JP5049448B2 (en) |
KR (1) | KR20030051630A (en) |
CN (2) | CN102445546A (en) |
AR (1) | AR031383A1 (en) |
AT (1) | ATE453724T1 (en) |
AU (2) | AU2001284147B2 (en) |
BR (1) | BR0113558A (en) |
CA (1) | CA2420617A1 (en) |
CZ (2) | CZ2003600A3 (en) |
DE (1) | DE60140948D1 (en) |
ES (1) | ES2337879T3 (en) |
FR (1) | FR2813395B1 (en) |
HU (1) | HUP0500620A2 (en) |
MX (1) | MXPA03001841A (en) |
PL (1) | PL361139A1 (en) |
RU (1) | RU2310200C2 (en) |
WO (1) | WO2002018628A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2813395B1 (en) | 2000-08-28 | 2003-01-24 | Stago Diagnostica | METHOD OF IN VITRO DETERMINATION OF SOLUBLE FIBRIN BY GENERATION OF SPECIFIC DEGRADATION PRODUCTS |
FR2900734B1 (en) * | 2006-05-05 | 2009-03-06 | Diagnostica Stago Soc Par Acti | DETECTION OF THROMBOEMBOLIC VENOUS DISEASES BY THE ASSAY OF D-DIMERS AND SOLUBLE FIBRIN |
FR2948666A1 (en) | 2009-07-30 | 2011-02-04 | Univ Paris Curie | METHOD OF DIAGNOSING CANCER AND DETERMINING SEVERITY OF CANCER IN AN INDIVIDUAL |
WO2012014996A1 (en) * | 2010-07-30 | 2012-02-02 | シスメックス株式会社 | Reagent and reagent kit for measurement of fdp, and measurement method |
CN104458367B (en) * | 2014-11-06 | 2019-03-26 | 上海长岛生物技术有限公司 | A kind of d-dimer and the compound quality-control product of FDP and preparation method thereof |
CN104459103B (en) * | 2014-12-15 | 2016-04-27 | 中国医学科学院输血研究所 | The preparation method of D-dimer quality control product |
WO2017146119A1 (en) * | 2016-02-22 | 2017-08-31 | 株式会社Lsiメディエンス | Measurement reagent for crosslinked fibrin degradation product, and measurement method |
CA3078625C (en) | 2017-10-09 | 2023-01-17 | Terumo Bct Biotechnologies, Llc | Lyophilization container and method of using same |
CA3130668A1 (en) | 2019-03-14 | 2020-12-03 | Terumo Bct Biotechnologies, Llc | Multi-part lyophilization container and method of use |
RU2703541C1 (en) * | 2019-03-15 | 2019-10-21 | федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр профилактической медицины" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ПМ" Минздрава России) | Method for determining fibrinogen during recalcification of citrate plasma and evaluating its functionality |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE447579B (en) * | 1985-04-01 | 1986-11-24 | Biopool Ab | SOLUBILIZABLE, FIBRIN-BASED COMPOSITION AND USE OF THE COMPOSITION IN DETERMINING FIBRINOLY PARAMETERS |
US5114845A (en) * | 1987-07-06 | 1992-05-19 | Biopool International, Inc. | Assays for plasminogen activator inhibitor and soluble fibrin |
ATE185376T1 (en) * | 1987-07-06 | 1999-10-15 | Biopool Int Inc | METHOD FOR MEASURING TISSUE PLASMINOGEN ACTIVATOR, ANTITHROMBIN-III AND SOLUBLE FIBRIN |
US5175087A (en) * | 1987-07-06 | 1992-12-29 | Biopool International, Inc. | Method of performing tissue plasminogen activator assay |
DE3730059A1 (en) * | 1987-09-08 | 1989-03-30 | Behringwerke Ag | METHOD FOR DETERMINING "SOLUBLE" FIBRINE |
US5453359A (en) * | 1988-06-13 | 1995-09-26 | American Biogenetic Sciences, Inc. | Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers |
IE67430B1 (en) * | 1988-06-24 | 1996-04-03 | Res Corp Technologies Inc | Assay for soluble crosslinked fibrin polymers |
US5206140A (en) * | 1988-06-24 | 1993-04-27 | Research Corporation Technologies, Inc. | Assay for soluble crosslinked fibrin polymers |
US5041376A (en) * | 1988-12-09 | 1991-08-20 | The Board Of Regents Of The University Of Texas System | Method for identifying or shielding functional sites or epitopes of proteins that enter the exocytotic pathway of eukaryotic cells, the mutant proteins so produced and genes encoding said mutant proteins |
DE69435072T2 (en) * | 1993-11-02 | 2009-01-29 | Mitsubishi Kagaku Iatron, Inc. | ANTIBODY AGAINST HUMAN SOLUBLE FIBRIN, HYBRIDOME THAT YOU PRODUCE AND IMMUNE MEASUREMENT PROCEDURE |
JP2001502895A (en) * | 1996-09-20 | 2001-03-06 | ザ・ジェネラル・ホスピタル・コーポレイション | Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin |
JP3472138B2 (en) * | 1998-06-02 | 2003-12-02 | 帝国臓器製薬株式会社 | Method for measuring monoclonal antibody and FDP |
FR2813395B1 (en) | 2000-08-28 | 2003-01-24 | Stago Diagnostica | METHOD OF IN VITRO DETERMINATION OF SOLUBLE FIBRIN BY GENERATION OF SPECIFIC DEGRADATION PRODUCTS |
FR2900734B1 (en) * | 2006-05-05 | 2009-03-06 | Diagnostica Stago Soc Par Acti | DETECTION OF THROMBOEMBOLIC VENOUS DISEASES BY THE ASSAY OF D-DIMERS AND SOLUBLE FIBRIN |
-
2000
- 2000-08-28 FR FR0010999A patent/FR2813395B1/en not_active Expired - Lifetime
-
2001
- 2001-07-23 AR ARP010103515A patent/AR031383A1/en not_active Application Discontinuation
- 2001-08-17 CN CN2011102910027A patent/CN102445546A/en active Pending
- 2001-08-17 AT AT01963106T patent/ATE453724T1/en not_active IP Right Cessation
- 2001-08-17 AU AU2001284147A patent/AU2001284147B2/en not_active Ceased
- 2001-08-17 DE DE60140948T patent/DE60140948D1/en not_active Expired - Lifetime
- 2001-08-17 BR BR0113558-9A patent/BR0113558A/en not_active IP Right Cessation
- 2001-08-17 AU AU8414701A patent/AU8414701A/en active Pending
- 2001-08-17 JP JP2002522534A patent/JP5049448B2/en not_active Expired - Fee Related
- 2001-08-17 ES ES01963106T patent/ES2337879T3/en not_active Expired - Lifetime
- 2001-08-17 CA CA002420617A patent/CA2420617A1/en not_active Abandoned
- 2001-08-17 MX MXPA03001841A patent/MXPA03001841A/en not_active Application Discontinuation
- 2001-08-17 EP EP01963106A patent/EP1313877B1/en not_active Expired - Lifetime
- 2001-08-17 WO PCT/FR2001/002628 patent/WO2002018628A1/en active IP Right Grant
- 2001-08-17 KR KR10-2003-7002841A patent/KR20030051630A/en not_active Application Discontinuation
- 2001-08-17 CZ CZ2003600A patent/CZ2003600A3/en unknown
- 2001-08-17 CN CN01815715A patent/CN1458980A/en active Pending
- 2001-08-17 PL PL36113901A patent/PL361139A1/en not_active Application Discontinuation
- 2001-08-17 RU RU2003108504/15A patent/RU2310200C2/en not_active IP Right Cessation
- 2001-08-17 HU HU0500620A patent/HUP0500620A2/en unknown
- 2001-08-28 CZ CZ20013111A patent/CZ20013111A3/en unknown
-
2003
- 2003-02-25 US US10/373,614 patent/US8883433B2/en not_active Expired - Fee Related
-
2011
- 2011-09-23 US US13/242,996 patent/US9081024B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ATE453724T1 (en) | 2010-01-15 |
JP2004507745A (en) | 2004-03-11 |
BR0113558A (en) | 2003-08-05 |
ES2337879T3 (en) | 2010-04-30 |
WO2002018628A1 (en) | 2002-03-07 |
FR2813395B1 (en) | 2003-01-24 |
EP1313877B1 (en) | 2009-12-30 |
AU2001284147B2 (en) | 2007-05-17 |
CN1458980A (en) | 2003-11-26 |
US20030175839A1 (en) | 2003-09-18 |
FR2813395A1 (en) | 2002-03-01 |
US9081024B2 (en) | 2015-07-14 |
US20120070855A1 (en) | 2012-03-22 |
CZ20013111A3 (en) | 2002-04-17 |
CZ2003600A3 (en) | 2003-10-15 |
US8883433B2 (en) | 2014-11-11 |
HUP0500620A2 (en) | 2005-09-28 |
MXPA03001841A (en) | 2004-11-01 |
DE60140948D1 (en) | 2010-02-11 |
AU8414701A (en) | 2002-03-13 |
CN102445546A (en) | 2012-05-09 |
AR031383A1 (en) | 2003-09-24 |
EP1313877A1 (en) | 2003-05-28 |
KR20030051630A (en) | 2003-06-25 |
CA2420617A1 (en) | 2002-03-07 |
RU2310200C2 (en) | 2007-11-10 |
JP5049448B2 (en) | 2012-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9902971D0 (en) | Assay | |
AU8414701A (en) | Assay for soluble fibrin | |
AU2001284147A1 (en) | Assay for soluble fibrin | |
GB0012860D0 (en) | Assay | |
GB0003069D0 (en) | Improved assay | |
GB9900159D0 (en) | Assay | |
GB0008784D0 (en) | Assay | |
GB0005894D0 (en) | Assay | |
GB0101847D0 (en) | Assay | |
GB0005895D0 (en) | Novel assay | |
GB0014838D0 (en) | An assay | |
GB0010960D0 (en) | Assay | |
GB0002543D0 (en) | Assay method | |
GB0025804D0 (en) | Assay | |
GB0001703D0 (en) | Assay | |
GB0010565D0 (en) | Assay for acetylcholinesterase inhibitors | |
GB0003898D0 (en) | Assay | |
GB0023239D0 (en) | Assay | |
GB0013561D0 (en) | Assay | |
GB0019242D0 (en) | Assay | |
GB0024184D0 (en) | An assay | |
GB0024299D0 (en) | Assay method | |
GB0029001D0 (en) | Assay | |
GB0021461D0 (en) | Assay method | |
GB0001043D0 (en) | Assay |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |